Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C11H14ClN3O4S3 |
Molecular Weight | 383.895 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
NS(=O)(=O)C1=CC2=C(N[C@@H](CSCC=C)NS2(=O)=O)C=C1Cl
InChI
InChIKey=VGLGVJVUHYTIIU-LLVKDONJSA-N
InChI=1S/C11H14ClN3O4S3/c1-2-3-20-6-11-14-8-4-7(12)9(21(13,16)17)5-10(8)22(18,19)15-11/h2,4-5,11,14-15H,1,3,6H2,(H2,13,16,17)/t11-/m1/s1
Molecular Formula | C11H14ClN3O4S3 |
Molecular Weight | 383.895 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Synthesis and application of mono-2A-azido-2A-deoxyperphenylcarbamoylated beta-cyclodextrin and mono-2A-azido-2A-deoxyperacetylated beta-cyclodextrin as chiral stationary phases for high-performance liquid chromatography. | 2006 Jan 6 |
|
A case of brucellar spondylodiscitis involving the cervical spine. | 2009 |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/2191585
Aldactazine ( 25 mg spironolactone and 15 mg altizide, 1/day)
Route of Administration:
Oral
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 09:46:53 UTC 2023
by
admin
on
Sat Dec 16 09:46:53 UTC 2023
|
Record UNII |
D9KLS88BLV
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
D9KLS88BLV
Created by
admin on Sat Dec 16 09:46:53 UTC 2023 , Edited by admin on Sat Dec 16 09:46:53 UTC 2023
|
PRIMARY | |||
|
6604323
Created by
admin on Sat Dec 16 09:46:53 UTC 2023 , Edited by admin on Sat Dec 16 09:46:53 UTC 2023
|
PRIMARY | |||
|
2242522-74-1
Created by
admin on Sat Dec 16 09:46:53 UTC 2023 , Edited by admin on Sat Dec 16 09:46:53 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
RACEMATE -> ENANTIOMER |
|